drugset / Trial / NCT03408730

Lot-to-lot Consistency of Sci-B-Vac™ in Adults

NCT03408730

Phase 3 Completed 2838 enrolled VBI Vaccines Inc.
RandomizedParallel-groupTriple-blindPrevention

Summary

A Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults

Timeline

Start
2017-12-14
Primary completion
2019-10-01
Completion
2019-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Engerix-B Vaccine 20 ug Intramuscular
Subject Sci-B-Vac Vaccine 10 ug Intramuscular